News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
844,581 Results
Type
Article (86484)
Company Profile (651)
Press Release (757446)
Multimedia
Podcasts (148)
Webinars (19)
Section
Business (232373)
Career Advice (4130)
Deals (39755)
Drug Delivery (126)
Drug Development (90908)
Employer Resources (199)
FDA (18085)
Job Trends (17359)
News (395944)
Policy (39736)
Tag
Academia (2993)
Academic (1)
Accelerated approval (11)
Adcomms (28)
Allergies (89)
Alliances (56789)
ALS (96)
Alzheimer's disease (1537)
Antibody-drug conjugate (ADC) (172)
Approvals (18045)
Artificial intelligence (290)
Autoimmune disease (35)
Automation (15)
Bankruptcy (402)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (448)
Bladder cancer (90)
Brain cancer (31)
Breast cancer (308)
Cancer (2603)
Cardiovascular disease (171)
Career advice (3539)
Career pathing (34)
CAR-T (195)
CDC (26)
Cell therapy (528)
Cervical cancer (19)
Clinical research (73668)
Collaboration (974)
Company closure (3)
Compensation (587)
Complete response letters (32)
COVID-19 (2862)
CRISPR (60)
C-suite (304)
Cystic fibrosis (112)
Data (2614)
Decentralized trials (2)
Denatured (52)
Depression (58)
Diabetes (236)
Diagnostics (6800)
Digital health (10)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (140)
Drug pricing (117)
Drug shortages (19)
Duchenne muscular dystrophy (114)
Earnings (96084)
Editorial (41)
Employer branding (25)
Employer resources (169)
Events (129824)
Executive appointments (725)
FDA (19356)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (807)
Gene editing (125)
Generative AI (26)
Gene therapy (392)
GLP-1 (793)
Government (5188)
Grass and pollen (4)
Guidances (134)
Healthcare (20760)
HIV (31)
Huntington's disease (32)
IgA nephropathy (41)
Immunology and inflammation (164)
Immuno-oncology (11)
Indications (32)
Infectious disease (3004)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (53)
Intellectual property (102)
Interviews (813)
IPO (17766)
IRA (42)
Job creations (5192)
Job search strategy (2863)
Kidney cancer (14)
Labor market (57)
Layoffs (578)
Leadership (25)
Legal (10071)
Liver cancer (76)
Longevity (10)
Lung cancer (372)
Lymphoma (188)
Machine learning (9)
Management (65)
Manufacturing (367)
MASH (95)
Medical device (14328)
Medtech (14333)
Mergers & acquisitions (22402)
Metabolic disorders (728)
Multiple sclerosis (92)
NASH (22)
Neurodegenerative disease (128)
Neuropsychiatric disorders (28)
Neuroscience (2167)
NextGen: Class of 2025 (7671)
Non-profit (5063)
Now hiring (48)
Obesity (375)
Opinion (284)
Ovarian cancer (93)
Pain (86)
Pancreatic cancer (96)
Parkinson's disease (168)
Partnered (20)
Patents (244)
Patient recruitment (142)
Peanut (51)
People (65284)
Pharmaceutical (131)
Pharmacy benefit managers (16)
Phase I (22786)
Phase II (32053)
Phase III (24037)
Pipeline (1425)
Policy (207)
Postmarket research (3542)
Preclinical (10287)
Press Release (72)
Prostate cancer (118)
Psychedelics (41)
Radiopharmaceuticals (258)
Rare diseases (453)
Real estate (7391)
Recruiting (76)
Regulatory (26761)
Reports (58)
Research institute (2652)
Resumes & cover letters (650)
Rett syndrome (6)
RNA editing (10)
RSV (41)
Schizophrenia (86)
Series A (152)
Series B (96)
Service/supplier (25)
Sickle cell disease (55)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4297)
State (2)
Stomach cancer (12)
Supply chain (54)
Tariffs (52)
The Weekly (94)
Vaccines (816)
Venture capital (55)
Weight loss (244)
Women's health (46)
Worklife (20)
Date
Today (77)
Last 7 days (317)
Last 30 days (1502)
Last 365 days (25745)
2025 (14216)
2024 (34043)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1267)
Alabama (63)
Alaska (6)
Arizona (255)
Arkansas (8)
Asia (50215)
Australia (8842)
California (6535)
Canada (1841)
China (651)
Colorado (201)
Connecticut (255)
Delaware (170)
Europe (114911)
Florida (842)
Georgia (183)
Hawaii (2)
Idaho (64)
Illinois (518)
India (27)
Indiana (315)
Iowa (16)
Japan (188)
Kansas (116)
Kentucky (19)
Louisiana (10)
Maine (58)
Maryland (952)
Massachusetts (5099)
Michigan (198)
Minnesota (345)
Mississippi (2)
Missouri (60)
Montana (25)
Nebraska (26)
Nevada (68)
New Hampshire (52)
New Jersey (1829)
New Mexico (27)
New York (1837)
North Carolina (1111)
North Dakota (9)
Northern California (2891)
Ohio (190)
Oklahoma (14)
Oregon (45)
Pennsylvania (1324)
Puerto Rico (17)
Rhode Island (27)
South America (1650)
South Carolina (8)
South Dakota (1)
Southern California (2444)
Tennessee (40)
Texas (886)
United States (23906)
Utah (142)
Virginia (130)
Washington D.C. (48)
Washington State (591)
West Virginia (2)
Wisconsin (50)
844,581 Results for "passage bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
June 23, 2025
·
8 min read
Press Releases
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
May 14, 2025
·
8 min read
Press Releases
Passage Bio to Participate in Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
Press Releases
Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights
March 5, 2025
·
10 min read
Pharm Country
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Passage Bio, Inc. today announced that William Chou, M.D., president and chief executive officer, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 4:00 p.m. ET.
June 5, 2024
·
1 min read
Press Releases
Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
November 6, 2024
·
1 min read
Pharm Country
Passage Bio to Participate in Upcoming March 2024 Investor Conferences
Passage Bio, Inc., a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, announced that management will participate in the following upcoming investor conferences.
February 27, 2024
·
1 min read
Business
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Passage Bio, Inc., a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, reported financial results for the first quarter ended March 31, 2024 and provided recent business highlights.
May 14, 2024
·
9 min read
Press Releases
Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
January 13, 2025
·
11 min read
1 of 84,459
Next
